Wellington Management Group
CRBP icon

Wellington Management Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Wellington Management Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,679
Closed -$291K – 1960
2024
Q4 		$291K Buy
24,679
+878
+4% +$14.7K ﹤0.01% 1879
2024
Q3 		$491K Buy
+23,801
New +$1.22M ﹤0.01% 1819

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wellington Management Group's CRBP Position: Q1 2025 in Review

Wellington Management Group sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 24,679 shares — an estimated $291K sold.

Wellington Management Group first reported a position in CRBP in Q3 2024 and held it in 2 quarters. The position peaked at $491K in Q3 2024. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

  • Wellington Management Group reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 24,679 Corbus Pharmaceuticals shares in Q1 2025, an estimated $291K.
  • Wellington Management Group first reported a position in Corbus Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Wellington Management Group's Corbus Pharmaceuticals position peaked at $491K in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.